Please use this identifier to cite or link to this item: http://hdl.handle.net/10790/3015

Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014

File Description SizeFormat 
TCA Midyear Poster 2016 PDF_So_Taira.pdfpdf3.87 MBAdobe PDFView/Open

Item Summary

Title: Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014
Authors: So, Nadine W.
Taira, Deborah
Keywords: Antidepressive Agents, Tricyclic
Medicare Part D
Inappropriate Prescribing
Physicians' practice patterns
Issue Date: 11 Apr 2017
Abstract: Tricyclic antidepressants were the primary pharmacologic treatment for depression in the United States from the 1960s to the late 1980s. Since then, other classes of antidepressants, such as Selective Serotonin Reuptake Inhibitors, have replaced its use as first-line agents due to their more favorable side-effect profile and proven equal efficacy. Tricyclic antidepressants are included in the Beers Criteria because of their potentially harmful side effects in the elderly (e.g. cognitive impairment, delirium, sedation, and orthostatic hypotension). The purpose of this study is to evaluate the changes in prescribing
of tricyclic antidepressants from 2013 to 2014 in Medicare beneficiaries.
Description: Pdf
Pages/Duration: 1 poster
URI/DOI: http://hdl.handle.net/10790/3015
Rights: This item is licensed under a Creative Commons License.
Appears in Collections:DKICP Student Research Projects



This item is licensed under a Creative Commons License Creative Commons